Trade JnJ JNJ

Sell
 Buy

JnJ live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

JnJ news

Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices
The Bank of Japan
Neil Wilson 2024 Jan 18, 08:07

Week ahead: ECB, BoJ rate decisions + Tesla earnings on tap

Forex Indices

Latest news

Show more
Frances Wang 2025 May 05, 16:00

XRP news today: Ripple Launches First-of-Its-Kind $25M RLUSD Fund

Cryptocurrencies
Tommy Yap 2025 May 05, 16:00

Morning Note: Cautious Optimism on US-China Trade; AMD & Arista Reports Loom

Morning Note Tech
Tommy Yap 2025 May 04, 16:00

Morning Note: Palantir's Report in Focus; Stable Swiss CPI; US Services Data Due

Morning Note Tech
an alarm clock with an arrow going up and down
Tommy Yap 2025 May 03, 21:00

Week Ahead: Fed and BoE Interest Rate Announcements in the Spotlight

Forex Indices
Frances Wang 2025 Apr 29, 16:00

Tariff news today: Trump softens car tariffs, Amazon to display tariff costs

Fed
Tommy Yap 2025 Apr 29, 16:00

Morning Note: Aussie CPI Up Slightly; Canada GDP Looms; US PCE Watch

Morning Note AUD CAD
Frances Wang 2025 Apr 28, 16:00

Bond ETFs Performance 2025: Risk Factors Associated with Bond ETFs

ETFs
Tommy Yap 2025 Apr 28, 16:00

Morning Note: UK Food Costs Spike; Earnings Watch for Visa & Coke

Morning Note

Info

Spread

0.97

Spread (%)

0.6292 %

Leverage

1:2

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Wednesday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

372940865536

Shares Outstanding

2406070016

Earnings Date (Next)

2001-06-13

instr__dividend_date

2025-06-10

instr__ex_dividend_date

2025-05-27

instr__forward_annual_dividend_rate

5.2

instr__forward_annual_dividend_yield

0.0335

EPS

8.99

Learn more about this instrument

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Markets.com Bonus Trading
Trustpilot